A detailed history of Ellsworth Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ellsworth Advisors, LLC holds 20,788 shares of CRL stock, worth $3.77 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares
20,788
Holding current value
$3.77 Million
% of portfolio
1.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$187.96 - $245.29 $3.91 Million - $5.1 Million
20,788 New
20,788 $4.1 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.23B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Ellsworth Advisors, LLC Portfolio

Follow Ellsworth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellsworth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ellsworth Advisors, LLC with notifications on news.